Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2016 May 17.
Published in final edited form as: Methods Mol Biol. 2016;1365:243–261. doi: 10.1007/978-1-4939-3124-8_13

Actin-Dynamics in Plant Cells: The Function of Actin Perturbing Substances Jasplakinolide, Chondramides, Phalloidin, Cytochalasins, and Latrunculins

Andreas Holzinger, Kathrin Blaas
PMCID: PMC4869834  EMSID: EMS67976  PMID: 26498789

Abstract

This chapter will give an overview of the most common F-actin perturbing substances, that are used to study actin dynamics in living plant cells in studies on morphogenesis, motility, organelle movement or when apoptosis has to be induced. These substances can be divided into two major subclasses – F-actin stabilizing and polymerizing substances like jasplakinolide, chondramides and F-actin severing compounds like chytochalasins and latrunculins. Jasplakinolide was originally isolated form a marine sponge, and can now be synthesized and has become commercially available, which is responsible for its wide distribution as membrane permeable F-actin stabilizing and polymerizing agent, which may even have anti-cancer activities. Cytochalasins, derived from fungi show an F-actin severing function and many derivatives are commercially available (A, B, C, D, E, H, J), also making it a widely used compound for F-actin disruption. The same can be stated for latrunculins (A, B), derived from red sea sponges, however the mode of action is different by binding to G-actin and inhibiting incorporation into the filament. In the case of swinholide a stable complex with actin dimers is formed resulting also in severing of F-actin.

For influencing F-actin dynamics in plant cells only membrane permeable drugs are useful in a broad range. We however introduce also the phallotoxins and synthetic derivatives, as they are widely used to visualize F-actin in fixed cells. A particular uptake mechanism has been shown for hepatocytes, but has also been described in siphonal giant algae. In the present chapter the focus is set on F-actin dynamics in plant cells where alterations in cytoplasmic streaming can be particularly well studied; however methods by fluorescence applications including phalloidin- and antibody staining as well as immunofluorescence-localization of the inhibitor drugs are given.

Keywords: Actin filaments, Chondramides, Cytochalasins, Depsipeptide, Jasplakinolide, Latrunculin, Phalloidin, Phallotoxin, Swinholide

1. Introduction

Filamentous Actin (F-actin), as a major structural cytoskeletal component has been targeted by inhibitor drugs over decades and the importance of an undisturbed turnover has been established as prerequisite for living functions in plant cells. Yet, a comprehensive overview of the different categories of F-actin perturbing substances is still missing. We will here give a short overview on (A) actin stabilizing and polymerizing substances like jasplakinolide, chondramide and phalloidin, actin depolymerizing substances like cytochalasin, latrunculin and swinholide (Fig. 1).

Fig. 1.

Fig. 1

Molecular structures of a selection of F-actin stabilizing/polymerizing drugs (jasplakinolide, phalloidin, chondramide) and F-actin disrupting drugs (cytochalasin A, cytochalasin D, latrunculin A, latrunculin B, swinholide A).

The actin system is involved in different cellular processes like exo- and endocytosis, organelle motions and maintenance of organelle distribution, motility, cell division and cytoplasmic streaming. Several substances are known to influence these processes by altering intracellular actin organization and have been used extensively for cell biological research (1). While the mechanism of action is different for the described substances, the effect on the cells might be quite similar – a disruption of the actin related functions.

The present article does not cover drugs or inhibitors acting only indirectly on F-actin polymerization (i.e. ATP-synthase blockers like ATPase-blockers N-ethylmaleimide (NEM) and 2,3-butanedione monoxime (BDM) (2)) or inhibitors interacting with actin binding proteins like the Arp2/3 komplex (i.e. wiskostatin, (3)).

1.1. F-Actin stabilizing and polymerizing substances

Actin stabilization is generated mostly by three different compounds: phalloidin (4, 5), jasplakinolide (6, 7) and chondramide (8, 9). While all three substances have the capacities to stabilize F-actin, phalloidin is not membrane permeable, while jaslplakinolide and chondramides readily enter cells (10, 11); Therefor phalloidin is used in cell biological research mainly for visualization of F-actin after fluorescence labeling of the compound in fixed tissues (12). In contrast, the commercially available jasplakinolide can be used for F-actin stabilization in living cells due to its membrane permeability (13).

1.1.1. Jasplakinolide

The common feature of these actin stabilizing substances is a cyclic depsipeptide (Fig. 1), which is a polymeric compound containing both, amino acids and hydroxy acids, joined by peptide and ester bounds. Chemically jasplakinolide is a cyclo-depsipeptide containing a tripeptide moiety linked to a polyketide chain (14, 15), (Fig. 1). Jasplakinolide is also called jaspamide (15, 16, 17, 18), For jasplakinolide also F-actin polymerizing capacities were described (19, 20, 21, 22, 23).

Originally jasplakinolide was isolated from the marine sponge Jaspis sp. collected at Fiji or the Palau islands (14, 16). The sponge was authenticated as Jaspis johnstoni (15), however taxonomic difficulties were pointed out (24) and the compound can also be isolated form other sponge genera (24, 25). Detailed procedures for jasplakinolide extraction can be found in (26).

Different approaches were made to synthesize this substance (27, 28) or generate nonpeptide mimetics (29), finally Jasplakinolide became commercially available from Molecular Probes in the late 90s. An enantioselective total synthesis of (+)-jasplakinolide has been described recently (30).

The biological activities of jasplakinolide are described as anthelminthic, antifungal, insecticidal and selective antimicrobial (14, 16, 31). In vitro investigations have elucidated the actin polymerizing- and stabilizing capacities of jasplakinolide (7, 19, 23).

In plant systems the unicellular green alga Micrasterias (20), green algae Acetabularia, Pseudobryopsis and Nitella (11), fucoid (brown algal) Zygotes of Silvetia compressa and Pelvetia compressa (32), Allium bulb scale cells and Sinapis root hairs (11), tobacco BY-2 cells (33), Lilium pollen tubes (34), Papaver rhoeas pollen tubes (35) have been tested for jasplakinolide reaction.

Jaspalkinolide causes tremendous effect already visible at the light microscopic level by malformation of cells after recovery in the development of Micrasteris (20) (Fig. 2 a). Inhibition or retardation of cell development occurs; during recovery from drug treatment the cells develop a malformed pattern (20). In pollen tubes the normal bidirectional cytoplasmic streaming is altered, instead a rotary streaming is observed in the swollen apex (34). Moreover altering F-actin levels or dynamics by jasplakinolide plays a functional role in initiating programmed cell death in Papaver pollen, triggering a caspase-3-like activity (35). Polarity establishment is severely changed in fucoid zygotes (32). When applied during mitosis, binucleated cells are generated as a consequence of jasplakinolide treatment (20).

Fig. 2.

Fig. 2

Light microscopy of F-actin perturbation. a Effect of jasplakinolide treatment on developing Micrasterias denticulata cell (Subheading 3.1.) young developmental stage treated with 3 µM jasplakinolide for 0.5 h and allowed to recover for 3 h in nutrient solution, young semi-cell exhibits complete loss of normal cell pattern (arrow), chloroplast (chl). b Effect of 5 µm latrunculin B on Oxyria digyna mesophyll cell; cytoplasmic streaming is inhibited, between the chloroplasts (chl) granular cytoplasmic portions are visible. Bars: a 20 µm, b 5 µm. a reprinted from reference (20) with permission. ‘Copyright Wiley-Liss, Inc., a subsidiary of John Wiley & Sons, Inc’. b reprinted from reference (55) with permission of ‘G. Thieme Verlag KG, Stuttgart.’

Jasplakinolide specifically targets F-actin, other cytoskeletal components like desmin or ß-tubulin were not influenced by jasplakinolide (36), microtubule dependent processes are not affected (37) and the distribution of microtubules and microtubule dependent processes were not altered in green algae (20).

1.1.2. Chondramides

Another group of substances with actin stabilizing and polymerizing capacities are chondramides (9, 38). These depsipeptides were originally obtained from myxobacteria of Chondromyces crocatus (8, 39), Chemically they are very similar to jasplakinolide, but contain instead of an 19-membered ring an 18-membered macrocyclic ring (40). Until to date they are underrepresented due to their limited availability. However, synthetic chondramides were produced recently (40), and may become commercially available. In future, chondramides may also be used for cancer therapy (41, 42).

1.2. Actin depolymerizing substances

A prerequisite for an F-actin perturbing drug is it´s membrane permeability. Cytochalasins as well as latrunculines represent the most widely used F-actin sequestering drugs (43).

1.2.1. Cytochalasins

Cytochalasins have been shown to act on cytoplasmic streaming in plant cells (44, 45, 46, 47). A vast number of different cytochalasins (A, B, C, D, E, H, J) have been described, with different inhibitory concentrations and chemical properties, occasionally termed cytochalasanes (48). It is generally accepted that the cytochalasins slow the rate of filament polymerization by inhibiting the rate of elongation (49); This action is caused by the high affinity binding of cytochalasins to the barbed (plus end) of F-actin, thus the monomer addidion is prevented by a ‘capping’ mechanism (43, 49). Due to the prevention of G-actin incorporation into the filament, a net-depolymerization is provoked (43). While the main target is the F-actin cytoskeleton, for cytochalasins A and B also inhibit monosaccharide transport across the plasma membrane (5).

Cytochalasins are fungal metabolites, independently discovered and isolated from distinct fungal species (cytochalasin A and B derived from Helminthosporium dematioideum; cytochalasin C and D from Metarhizium anisopliae) by Aldridge et al. (50). Previously, Rothweiler and Tamm (51) termed the substance ‘phomin’ as it was detected in Phomas sp. (Fungi imperfecti, strain S 298). Chemically cytochalasins are a diverse group of polyketide–amino acid hybrid metabolites (48).

Various cytochalasins have a wide range of biological activities, some of which not directly related to actin binding. Some cytochalasins (e.g. cytochalasin B) interfere with the monosaccharide transport systems by binding to high-affinity sites on glucose-transporter proteins and may interfere with hormones.

1.2.2. Latrunculins

Latrunculins (Fig. 1) provide another useful drug for the study of actin polymerization with a complementary mode of action when compared to cytochalasin (52). The main mechanism of latrunculin action is in an interaction with actin monomers (G-actin) in order to avoid actin polymerization (52). It has been shown by an in vitro assay that latrunculins bind to purified G-actin resulting in a nonpolymerizable 1:1 complex (6). Latrunculin A is a toxin purified from the red sea sponge Latrunculia magnifica (52, 53). It has been used in a variety of plant cells inhibiting pollen germination and pollen tube growth (47) and induced plant dwarfism (54). Both Latrunculins arrested cytoplasmic streaming after disrupting the subcortical actin bundles (46). In a mesophyll cell of the high alpine plant Oxyria digyna latrunculin B arrested cytoplasmic streaming (Fig. 2b) (55). Latrunculin B has a diminished binding capacity when compared to latrunculin A (6).

1.2.3. Swinholide

Swinholide A (Fig. 1) was isolated from the marine sponge Theonella swinhoei, collected from the Red Sea (6, 56). It is membrane permeable and acting as an F-actin disrupting toxin that stabilizes actin dimers and thus severs F-actin. Chemically it consists of a 44-carbon ring dimeric dilactone macrolide with a 2-fold axis of symmetry (57, 58). The effects of swinholide A on the actin cytoskeleton and cell morphology are similar to latrunculins rather than of cytochalasins (57).

1.3. Visualization of inhibitory effects

The function of these drugs can be either studied by arresting or inhibiting the cytoplasmic streaming (Fig. 2b) (55). The velocity of cytoplasmic streaming can provide useful insights in the function of the different drugs (46).

Visualization of the changes in F-actin is usually performed by phalloidin staining (46). It has been showin in the charophyte green alga Nitella pseudoflabellata, that thick F-actin bundles may not appear influenced by e.g. cytochalasin A and H (Fig. 3), despite that the cytoplasmic streaming is arrested. After jasplakinolide or chondramide treatment an altered F-actin distribution was found, characterized by a patchy appearance of cortical actin (59), the formation of actin dots (60) or a disruption of the actin cytoskeleton (11, 36).

Fig. 3.

Fig. 3

Subcortical F-actin bundles in intermodal cells of Nitella pseudoflabellata treated with 1 µM cytochalasin A, 1 d, b cytochalasin H 50 µM 2 d. Despite these concentrations lead to an arresting of cytoplasmic streaming, the F-actin bundles are clearly visible after phalloidin staining with the perfusion method (see Subheading 3.2.4) clear cytoplasm. Reprinted from reference (46) with permission of Oxford University Press.

As competitive binding inhibition of phalloidin to F-actin by jasplakinolide is described (19), and decreased FITC-phalloidin labeling is noted as a consequence of jasplakinolide treatment in MDCK cells (61), the problems visualizing jasplakinolide effects by fluorescently labeled phalloidin are obvious. Moreover, phalloidin and jasplakinolide have the same effect when applied to living Dictyostelium cells, namely the formation of actin aggregates (22).

In order to avoid the difficulties mentioned, only electron microscopy appears to be a sufficient technique for detection of jasplakinolide effects on F-actin (20, 62).

At electron micrographs tangential sections of F-actin can easily be recognized by the filament diameter of about 4-5 nm. In organisms like Micrasterias, where normally almost no bundling of F-actin occurs, and thus F-actin is hardly found at electron microscopical images, alterations causing extensive bundling of actin are easily detected (20) (Fig. 3). Also immunodetection of the altered F-actin system after jasplakinolide treatment is successful (59) and allows a comprehensive picture to be drawn in combination with other techniques.

Herein different procedures shall be described for the detection of actin filament aggregates generated by application of jasplakinolide. Due to the advantages of electron microscopy and/or immunomethods, these will be mentioned more in detail, however different protocols for phalloidin stainings will be given as they have been used for some organisms in combination with jasplakinolide treatment (22, 59, 61).

2. Materials

2.1. Cell cultures

  1. Micrasterias denticulata Bréb. (unicellular green algae) are used for light microscopy and electron microscopy (20) and immuno-electron microscopy since alterations in the cell shape caused by drug treatments are easily detected. The cells are grown in culture medium under semisterile conditions in a light/dark regime of 14/10 h at 20°C.

  2. Characean green algae (Chara sp., Nitella sp.), fresh collected or culture grown material

  3. Acetabularia acetabulum;

  4. Stably transformed Arabidopsis thaliana expressing a fusion construct of GFP with the actin binding domain 2 (ABD2) of the plant actin-binding protein fimbrin (63, 64).

2.2. Chemicals, Buffers, Solutions

2.2.1. Actin Perturbing Drugs and solvents

  1. Jasplakinolide, Mol. Wt. 709.68, (Molecular Weight 709.67, J4580-100UG Sigma-Aldrich). 100 µg diluted upon arrival in methanol to achieve 10 mM stock solution and kept refrigerated at -20°C (see Note 1).

  2. Chondramides (while the original isolate from myxobacteria (8, 39) is not commercially available, synthetic condramide A analogous have been produced, see ref. 40).

  3. Cytochalasins (all available from Sigma-Aldrich): cytochalasin A: M. Wt. 477.59, C6637-1MG; cytochalasin B: M. Wt. 479.61, C6762-1MG; cytochalasin C: M. Wt. 507.62, C30382-1MG; cytochalasin D: M. Wt. 507.62, C8273-1MG; cytochalasin E: M. Wt. 495.56, C2149-1MG; cytochalasin H: M. Wt. 493.63, C0889-5MG; cytochalasin J: M. Wt. 451.60 (currently not available).

  4. Latrunculin (A, B): LAT A: M. Wt. 421.55, L5163-100UG (Sigma-Aldrich); LAT B: M. Wt. 395.51, L5288-1MG (Sigma-Aldrich).

  5. Swinholide A, M. Wt. 1,389.87, S9810-10UG (Sigma-Aldrich).

  6. Phalloidin M. Wt. 788.87, P2141-1MG (Sigma-Aldrich).

  7. Methanol reagent.

  8. DMSO (dimethyl sulfoxide) reagent.

2.2.2. Chemicals, Buffers and Solutions for Electron Microscopy

  1. Cacodylic buffer: 50 mM cacodylic acid sodium salt, pH 7.2.

  2. Cacodylate-glutaraldehyde: 50 mM cacodylic buffer, 1% glutaraldehyde, pH 7.2.

  3. Cacodylate-osmium: 50 mM cacodylic acid buffer, 1% osmiumtetraoxide, 0.8%, potassium hexacyanoferrate III.

  4. Phosphate buffer-fixative: 25 mM sodium hydrogen phosphate, 25 mM potassium dihydrogen phosphate, 1% glutaraldehyde, 1% osmiumtetroxide, pH 6.2.

  5. Calcium chloride.

  6. 2% Aqueous uranyl acetate dihydrate.

  7. Ethanol solutions: 15%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 100%.

  8. 1,2- Propylene oxide reagent.

  9. Propylene oxide-ethanol mixture: 1,2- Propylene oxide and ethanol (1:1 v/v).

  10. A suitable embedding resin: Embed 812, Araldite 502, Spurr’s resin or others.

  11. Propylene oxide-embedding resin mixture: Mixture of 1,2 Propylene oxide and embedding resin (1:1 v/v).

  12. Formvar 1595 E.

  13. Chloroform reagent.

  14. Lead citrate.

2.2.3. Chemicals, Buffers and Solutions for Immunoelectron Microscopy

  1. Lecithin (10%) dissolved in chloroform.

  2. Liquid nitrogen.

  3. Acetone-tannic acid: acetone containing 0.1% tannic acid (v/v).

  4. Acetone-osmium: acetone containing 2% osmiumtetroxide and 0.05% uranyl acetate.

  5. LR white resin (London resin company, medium grade).

  6. TBS: Tris buffered saline, 50 mM, pH 7.5.

  7. Blocking solution: TBS containing 1% BSA (fraction V), 1% acetylated BSA, 01% Tween-20.

  8. 10% bovine calf fetal serum.

    Primary Antisera/Antibodies, e.g. monoclonal anti actin N 350 monoclonal anti actin (Amersham).

  9. 10 nm collodial gold conjugated, secondary antibody appropriate for the primary antibody.

2.2.4. Chemicals, Buffers and Solutions for Fluorescence Microscopy

  1. MT-stabilizing buffer (MTSB): 50 mM PIPES buffer, 50 mM MgSO4, 50 mM EGTA, pH 6.9

  2. Dimethylsulfoxide (DMSO) reagent.

  3. Paraformaldehyde fixative: 4% paraformaldehyde and cytospin (Cytospin 3 preparation systems, Shandon Scientific Ltd. Cheshire, UK).

  4. 50 µM ammonium chloride.

  5. PBS: Phosphate buffered saline: 137 mM sodium chloride, 2.7 mM potassium chloride, 4.3 mM sodium hydrogen phosphate, 1.4 mM potassium dihydrogen phosphate.

  6. Triton solution: 0.1% Triton X-100 in PBS.

  7. 2% bovine serum albumin (BSA).

  8. Anti actin monoclonal antibody N 350 (Amersham) (see Note 2).

  9. Anti actin monocolonal antibody (clone C4).

  10. Phalloidin: 0.4 mg/mL FITC (or alexa) conjugated phalloidin Alexa phalloidin (Molecular Probes, Leiden, The Netherlands; prepare from a 6.6 mM stock solution in methanol) at a concentration of 0.16 mM.

  11. Phenylenediamine.

  12. Texas red conjugated anitmouse IgM antibody (Jackson Immuno Research).

  13. Steedman´s wax: PEG 400 distearate and 1-hexadecanol mixed in proportions 9:1 (w/w) (68).

  14. Isotonic perfusion solution: 200mM sucrose, 70mM KCl, 4.5mM MgCl2, 5mM ethyleneglycoltetraacetic acid (EGTA), 1.48 mM CaCl2, 10mM piperazine-N, N´-bis (2-ethanesulfonic acid) (PIPES, pH7.0).

3. Methods

3.1. Treatment and Recovery Experiments

  1. Incubate cells (from the above mentioned plant cell types or tissue see Subheading 2.1) in 1 mL of culture medium containing respective inhibitory drug concentrations for time periods of 0.5, 1, 2, 3, 4, 24, 48 h and observe the effect on cytoplasmic streaming (Fig. 2, see Note 3).

  2. Incubate cells in 1 mL of culture medium containing the respective drug (see step 1), wash several times with culture medium and allow developing in culture medium for up to 24 h. This is regarded as ‘recovery experiment’.

  3. Investigate the cells treated as in steps 2. and 3. under a regular light microscope or fix for electron microscopy (see Subheadings 3.2.1).

3.2. Visualization of F-actin after drug treatment

3.2.1. Chemical Fixation/Electron Microscopy of Algal Cells after Holzinger and Meindl (20)

The procedure described herein has first been used for the unicellular green alga Micrasterias by (65).

  1. Fix treated cells, cells allowed to recover in nutrient solution and untreated control cells in cacodylate-gultaraldehyde for 15 min (see Note 4).

  2. Wash cells 3 times 5 min each in cacodylic buffer.

  3. Postfix cells in cacodylate-osmium for 2 h.

  4. Wash cells, as in step 2, 3 times 5 min each in distilled water.

  5. Incubate cells in 2% uranyl acetate for 2 h (see Note 5).

  6. Wash cells, as in step 2, 3 times 5 min each in distilled water.

  7. Dehydrate the cells in increasing concentrations of cold ethanol (see Note 6), 15 min per concentration:

    15%, 30%, 40%, 50%, 70%, 80%, 90%, 95%, 100%. Keep in 100% for 30 min.

  8. Transfer the cells to the propylene oxide-ethanol mixture, allow to equilibrate for 10 min, transfer to propylene oxide.

  9. Transfer the cells to the propylene oxide-embedding resin mixture (see Note 7).

  10. Rotate the cells in this mixture for 48 h in order to allow the propylene oxide to evaporate and a sufficient penetration of the cells with the resin to be achieved.

  11. Transfer the cells to freshly prepared resin in aluminum dishes and orientate them by the use of eyelashes connected to holders.

  12. Incubate in an exsikkator for 4 days.

  13. Polymerize the resin for 24 h at 60°C.

  14. Select cells and section at an ultramicrotome.

  15. Collect sections on formvar coated copper grids (see Note 8).

  16. Counterstain the sections with 2% uranyl acetate and Reynold´s lead citrate (see Note 9).

  17. Investigate and photograph at a transmission electron microscope at 60-80 kV.

3.2.2. Immuno-electron Microscopy

The following fixation technique has been carried out for Micrasterias for the first time by Meindl et al. (66). The recipe for actin detection by means of immunogoldlocalization is based on (67).

  1. Prepare gold or aluminum specimen holders with bed depths of 100 - 300 µm by dipping in lecithin.

  2. Collect treated cells to be transferred to specimen holders. Large cells like Micrasterias (200 µm in diameter) can be easily collected under a stereo microscope by wrapping with cotton fibers.

  3. Fix treated cells by high pressure freeze fixation by the use of a Hyperbaric freeze device (formally Balzers HPM 010, later taken over by BAL-TEC; then produced by ABRA Fluid AG, Widnau, Switzerland; currently available as “High Pressure Freezing Machine HPM 010” by Boeckeler Instruments Inc., Tucson/AZ, USA), for other methods (see Note 10).

  4. Collect and store samples under liquid nitrogen.

  5. Transfer samples to a freeze substitution device (Reichert-Jung, cs auto or LEICA EM AFS, Leica Microsysteme GmbH, Vienna, Austria).

  6. Substitute samples at -80°C for 24 h in acetone-tannic acid solution.

  7. Wash several times with acetone.

  8. Substitute samples at -80°C for 24 h in acetone-osmium solution (see Note 11).

  9. Allow samples to reach -30°C within 5 h.

  10. Continue substitution at -30°C for 10 h.

  11. Allow samples to reach room temperature (20°C) within 5 h.

  12. Remove osmium tetroxide/uranyl acetate solution and rinse several times with acetone.

  13. Change acetone for ethanol by several rinses.

  14. Transfer samples to LR white in aluminum dishes and cover with cellophane foil.

  15. Allow samples to infiltrate in an exsikkator for 24 h.

  16. Polymerize under UV light at room temperature for 24 h.

  17. Prepare sections for electron microscopy (compare 3.2.1) and transfer to formvar coated gold- or gilded copper grids.

  18. Incubate in blocking solution for 30 min up to 1 h. A blocking step with 10% bovine calf fetal serum may be applied if blocking is not sufficient.

  19. Transfer into primary antibody against actin. Purified antibody may be diluted in blocking solution. Incubation should last for 1.5 h at room temperature or for up to 24 h at 4°C.

  20. Wash 4 times 15 min in TBS by transferring grids to 50 µL droplets of TBS.

  21. Incubate in 10 nm-gold (see Note 12) labeled secondary antibody diluted in blocking solution (see Note 13).

  22. Wash by rinsing with TBS, followed by incubation in droplets of TBS for 2 min, followed by a brief rinse with distilled water.

  23. Counterstain with uranyl acetate and lead citrate if necessary (see Subheading 3.2.1.).

  24. Investigate at a transmission electron microscope at 80 kV.

3.2.3. Immunofluorescence Microscopy of Latrunculin B treated Maize Roots after Baluska et al. (54, 68)

  1. Grow maize root tips for 48 h.

  2. Cut apical segments (6-8 mm) and transfer into 4.6 ml MTSB buffer mixed with 0.5 ml of DMSO for 15 min.

  3. Fix for 1 h in MTSB/DMSO solution containing 4% paraformaldehyde.

  4. Dehydrate in increasing ethanol series in PBS.

  5. Embed in Steedman´s wax by stepwise infiltration in proportions 2:1, 1:1 and 1:2 (v/v) for 2 h each step at 37°C.

  6. Infiltrate under vacuum three changes in pure wax.

  7. Polymerize wax at room temperature.

  8. Prepare longitudinal sections with a thickness between 4 and 8 µm.

  9. Mount sections on poly-L-lysine coated slides.

  10. Dewax the sections in ethanol.

  11. Rehydrate in ethanol/PBS series and incubate in MTSB for 45 min.

  12. Digest cell walls in 1% hemicellulose dissolved in 0.5 M EGTA, 0.4 M manniol, 1% Triton X-100, 0.3 mM phenlymethlysulphonyl fuoriede (dissolved in MTSB).

  13. Incubate in blocking solution (2 % BSA) for 30 min.

  14. Incubate in anti actin monoclonal anti-actin antibody (clone C4, ICN, Costa Mesa, CA) for 2 h at room temperature.

  15. Rinse 3 times 15 min in MTSB.

  16. Incubate in FITC-conjugated anti-mouse IgGs (diluted 1:100 -1:200) for 1 h at room temperature.

  17. Remove secondary antibody and mount in phenylenediamine.

  18. Examine at a Confocal Laser scanning microscope at excitation with an argon laser at 488 nm.

3.2.4. Perfusion of Nitella intermodal cells for FITC-phalloidin staining of F-actin after (46) (Fig. 3; see Note 14)

  1. Place an intermodal cell on the cover slip bottom of a perfusion chamber and press into vacuum grease lines; place small reservoirs with grooves over the grease and firmly press down without damaging the cells.

  2. Cover the central portion of the cell between the reservoirs with silicon fluid to avoid evaporation

  3. Bath the ends of the cells with isotonic perfusion solution.

  4. Reduce the turgor pressure of the cells in hypertonic solution.

  5. Cut the ends with small scissors and allow the perfusion solution to enter the cells.

  6. After 1 min replace the perfusion solution by an F-actin staining solution containing Alexa-phalloidin.

  7. After 20 min examine at the CLSM (see section 3.2.3)

4. Notes

  1. Jasplakinolide is also dissolvable in DMSO (31).

  2. The choice of the anti actin antibody is very important. The epitope of the N 350 (a mouse monoclonal IgM antibody directed against chicken gizzard actin) binding site is obviously not changed by jasplakinolide (11), whereas binding sites for other actin antibodies (eg. clone C4 – a mouse monoclonal IgG antibody directed against chicken gizzard actin, ICN) seem to be altered substantially which prevents visualization of F-actin after jasplakinolide treatment (11). This antibody may be used without problems in combination with latrunculine B treatment (54).

  3. The concentrations of the inhibitory drugs may vary drastically. For jasplakinolide was found to be effective at 1.5µM to 3 µM in producing F-actin aggregates for Micrasterias denticulate (20). Concentrations above 250 µM of jasplakinolide were lethal. The concentrations of jasplakinolide needed for other cells have to be found empirically. Variations in the literature range from as low as 100 nM to 1 µM, 2.5 µM to 10 µM (11, 32, 59, 69). However they should be in the same range as described herein, since the effective concentrations correlate with data obtained from the literature (22, 31, 61). Latrunculins had a different lowest effective concentrations in Micrasterias denticulata: chondramide A 20 µM, chondramide B 15 µM, chondramide C 5 µM, chondramide D 10 µM (38). In contrast in human tumor cell lines, 3-85 nM chondramide effectively inhibited prolifertation (9). For cytochalsins (46) found streaming-arresting concentration in Nitella pseudoflabellata between 1 and 200 µM. The lowest concentrations to arrest streaming were at 1 µM in cytochalasins A and E, 30 µM in cytochalasin H, 60 µM cytochalasin D and 200-220 µM in cytochalasins C, J, B. These authors distinguish between streaming arresting (i.e. fully arresting streaming within 1 h, Fig. 3) and streaming inhibiting (i.e. reducing streaming velocity by 15-80% within 1 h) concentrations. In another green alga Xanthidium armatum, cytochalasin D arrested cytoplasmic streaming at concentrations below 10 µM.

    In contrast, latrunculins have lower effective concentrations; Latruncunlin B may cause severe effects even at extremely low concentrations in the pM to nM range (45). Several authors use it in higher concentration in the µM range (10 µM (54); 5 µM, 10µM (55). Moreover, a combined treatment with latrunculins and cytochalasins, rapidly arrested cytoplasmic streaming even at concentrations that had only mild effects on the streaming rate when used separately (46). Swinholide has not been extensively applied to plant cells, only IC 50 values for human nasopharynx canger cells have been determined at 6 nM (70).

  4. The fixation procedure is performed in a ”Balzers Fixomat” - a device not commercially available anymore - consisting of sintered glass suction filters connected via a valve to a pump station, allowing to remove solutions by underpressure while cells remain in the filter. Moreover the temperature can be adjusted via a cooling bath. Alternatively the cells can be fixed in glass dishes, ideally in the shape of a hemisphere. In this case it is best to remove only the solutions with a pipette and not to transfer the cells.

    For other organisms more specialized methods might be necessary - for example embedding of the specimens in agarose prior to the fixation procedure.

  5. During incubation in uranyl acetate solution it is necessary to keep the cells in darkness, by covering the filter or dish with aluminum foil.

  6. During the whole procedure of dehydration the temperature should be kept at 6°C. At the steps 50% and 70% ethanol temperature might be lowered to 4°C. In case of fixation in round glass dishes they should be kept over ice. At the step of 100% ethanol the temperature should be increased to room temperature.

  7. Very good results are obtained with a 1:1 mixture of glycid ether 100 (a substance equivalent to Epon 812) and MNA. Prior to use DMP must be added (5 droplets to 10 ml of resin). However a mixture of Embed-812/Araldite 502/DDSA (DMP-30 or BDMA must be added prior to use) will also give adequate results. When different hardness has to be achieved, Spurr’s resin may be the best choice: As several components of the original mixture are not deliverable any more, we now use the kit “Agar Low Viscosity Resin (LV)” by Agar Scientific Ltd. Essex CM24 8DA, England.

  8. Coating of grids with formvar may not be necessary for all objects. We use the following procedure: A light microscopic slide is cleaned with lens tissue, tipped into 0.3 % formvar dissolved in chloroform. The resulting formvar film is cut at the edges of the slide and allowed to float on distilled water. Grids are placed on the film which is then removed with parafilm.

  9. The time periods needed for counterstaining depend on the staining already achieved during the fixation/staining procedure and are typically 5-30 min for uranyl acetate and 1-5 min for Reynold´s lead citrate.

  10. For large cells like Micrasterias (about 200 µm in diameter) high pressure freezing has been found the only appropriate technique for freeze fixation. Alternatively to the HPM 010, also the Leica EMPACT high pressure freezer (Leica Microsysteme GmbH, Vienna, Austria) gives reasonable results. However for small and less vacuolated cells plunge freezing which might be achieved with a relative simple equipment, will also give reasonable results.

  11. Osmium tetroxide dissolves well in acetone. Uranylacetat is best to be sonicated to dissolve it. For other organisms it might be appropriate to substitute without osmium tetroxide and uranyl acetate.

  12. Gold particles with 10 nm diameter are used commonly. The usage of smaller gold particles might enhance the accuracy of the detected locus.

  13. The actual dilution factor has to be found empirically for each system, but it should be in the range of 1:50 – 1:200.

  14. As mentioned in the introduction, the use of fluorescently labeled phalloidin is problematic due to competitive binding with jasplakinolide (19, 23). It has been reported that simultaneous addition of jasplakinolide and FITC-phalloidin (1:1) did not result in F-actin labeling, whereas addition of the inactive analogue jasplakinolide B and FITC-phalloidin resulted in staining as strong as in controls (11).

Fig. 4.

Fig. 4

Detail of the ultrastructure of Micrasterias denticulata cell treated with 3 µM jasplakinolide for 2 h and fixed for electron microscopy according to Subheading 3.2.1., dense accumulations of F-actin are visible in the cytoplasm. Bar = 0.2 µm. Reprinted from reference (20) with permission ‘Copyright Wiley-Liss, Inc., a subsidiary of John Wiley & Sons, Inc.’

Acknowledgements

We would like to thank Dr. Ilse Foissner, University of Salzburg, for providing the images in Fig. 3. This chapter was supported by FWF grant P24242-B16 to A.H.

References

  • 1.Allingham JS, Klenchin VA, Rayment I. Actin-targeting natural products: structures, properties and mechanisms of action. Cellular and molecular life sciences : CMLS. 2006;63(18):2119–2134. doi: 10.1007/s00018-006-6157-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Oertel A, Holzinger A, Lütz-Meindl U. Involvement of myosin in intracellular motility and cytomorphogenesis in Micrasterias. Cell Biology International. 2003;27(12):977–986. doi: 10.1016/j.cellbi.2003.07.004. [DOI] [PubMed] [Google Scholar]
  • 3.Guerriero CJ, Weisz OA. N-WASP inhibitor wiskostatin nonselectively perturbs membrane transport by decreasing cellular ATP levels. American journal of physiology. Cell physiology. 2007;292(4):C1562–6. doi: 10.1152/ajpcell.00426.2006. [DOI] [PubMed] [Google Scholar]
  • 4.Lynen F, Wieland U. Über die Giftstoffe des Knollenblätterpilzes IV. Justus Liebigs Ann Chem. 1937;533(1):93–117. doi: 10.1002/jlac.19385330105. [DOI] [Google Scholar]
  • 5.Cooper JA. Effects of cytochalasin and phalloidin on actin. The Journal of Cell Biology. 1987;105(4):1473–1478. doi: 10.1083/jcb.105.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Spector I, Braet F, Shochet NR, et al. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech. 1999;47(1):18–37. doi: 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  • 7.Bubb MR, Spector I, Beyer BB, et al. Effects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J Biol Chem. 2000;275(7):5163–5170. doi: 10.1074/jbc.275.7.5163. [DOI] [PubMed] [Google Scholar]
  • 8.Kunze B, Jansen R, Sasse F, et al. Chondramides A-D, New Antifungal and Cytostatic Depsipeptides from Chondromyces crocatus (Myxobacteria). Production, Physico-chemical and Biological Properties. J Antibiot. 1995;48(11):1262–1266. doi: 10.7164/antibiotics.48.1262. [DOI] [PubMed] [Google Scholar]
  • 9.Sasse F, Kunze B, Gronewold TMA, et al. The Chondramides: Cytostatic Agents From Myxobacteria Acting on the Actin Cytoskeleton. JNCI Journal of the National Cancer Institute. 1998;90(20):1559–1563. doi: 10.1093/jnci/90.20.1559. [DOI] [PubMed] [Google Scholar]
  • 10.Waldmann H, Hu T, Renner S, et al. Totalsynthese von Chondramid C und Bindung an F-Aktin. Angew Chem. 2008;120(34):6573–6577. doi: 10.1002/ange.200801010. [DOI] [Google Scholar]
  • 11.Sawitzky H, Liebe S, Willingale-Theune J, et al. The anti-proliferative agent jasplakinolide rearranges the actin cytoskeleton of plant cells. European Journal of Cell Biology. 1999;78(6):424–433. doi: 10.1016/S0171-9335(99)80085-5. [DOI] [PubMed] [Google Scholar]
  • 12.Peterson JR, Mitchison TJ. Small Molecules, Big Impact: A History of Chemical Inhibitors and the Cytoskeleton. Chemistry & Biology. 2002;9(12):1275–1285. doi: 10.1016/S1074-5521(02)00284-3. [DOI] [PubMed] [Google Scholar]
  • 13.Matthews JB, Smith JA, Hrnjez BJ. Effects of F-actin stabilization or disassembly on epithelial Cl- secretion and Na-K-2Cl cotransport. American Journal of Physiology - Cell Physiology. 1997;272(1):C254–C262. doi: 10.1152/ajpcell.1997.272.1.C254. [DOI] [PubMed] [Google Scholar]
  • 14.Crews P, Manes LV, Boehler M. Jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis sp. Tetrahedron Letters. 1986;27(25):2797–2800. doi: 10.1016/S0040-4039(00)84645-6. [DOI] [Google Scholar]
  • 15.Braekman JC, Daloze D, Moussiaux B, et al. Jaspamide from the Marine Sponge Jaspis johnstoni. J Nat Prod. 1987;50(5):994–995. doi: 10.1021/np50053a048. [DOI] [Google Scholar]
  • 16.Zabriskie TM, Klocke JA, Ireland CM, et al. Jaspamide, a modified peptide from a Jaspis sponge, with insecticidal and antifungal activity. J Am Chem Soc. 1986;108(11):3123–3124. doi: 10.1021/ja00271a062. [DOI] [Google Scholar]
  • 17.Fabian I, Halperin D, Lefter S, et al. Alteration of Actin Organization by Jaspamide Inhibits Ruffling, but not Phagocytosis or Oxidative Burst, in HL-60 Cells and Human Monocytes. Blood. 1999;93(11):3994–4005. [PubMed] [Google Scholar]
  • 18.Terracciano S, Bruno I, D'Amico E, et al. Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide. Bioorganic & medicinal chemistry. 2008;16(13):6580–6588. doi: 10.1016/j.bmc.2008.05.019. [DOI] [PubMed] [Google Scholar]
  • 19.Bubb MR, Senderowicz AM, Sausville EA, et al. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. Journal of Biological Chemistry. 1994;269(21):14869–14871. [PubMed] [Google Scholar]
  • 20.Holzinger A, Meindl U. Jasplakinolide, a novel actin targeting peptide, inhibits cell growth and induces actin filament polymerization in the green alga Micrasterias. Cell Motil Cytoskeleton. 1997;38(4):365–372. doi: 10.1002/(SICI)1097-0169(1997)38:4<365::AID-CM6>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  • 21.Sheikh S, Gratzer WB, Pinder JC, et al. Actin polymerisation regulates integrin-mediated adhesion as well as rigidity of neutrophils. Biochem Biophys Res Commun. 1997;238(3):910–915. doi: 10.1006/bbrc.1997.7407. [DOI] [PubMed] [Google Scholar]
  • 22.Lee E, Shelden EA, Knecht DA. Formation of F-actin aggregates in cells treated with actin stabilizing drugs. Cell Motil Cytoskeleton. 1998;39(2):122–133. doi: 10.1002/(SICI)1097-0169(1998)39:2<122::AID-CM3>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  • 23.Visegrády B, Lorinczy D, Hild G, et al. A simple model for the cooperative stabilisation of actin filaments by phalloidin and jasplakinolide. FEBS Lett. 2005;579(1):6–10. doi: 10.1016/j.febslet.2004.11.023. [DOI] [PubMed] [Google Scholar]
  • 24.Murray LM, Johnson A, Diaz MC, et al. Geographic variation in the tropical marine sponge Jaspis cf. johnstoni: An unexpected source of new terpene-benzenoids. J Org Chem. 1997;62:5638–5641. [Google Scholar]
  • 25.Fabian I, Shur I, Bleiberg I, et al. Growth modulation and differentiation of acute myeloid leukemia cells by jaspamide. Exp Hematol. 1995;23(7):583–587. [PubMed] [Google Scholar]
  • 26.Ayscough KR, Stryker J, Pokala N, et al. High rates of actin filament turnover in budding yeast and roles for actin in establishment and maintenance of cell polarity revealed using the actin inhibitor latrunculin-A. J Cell Biol. 1997;137(2):399–416. doi: 10.1083/jcb.137.2.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chu KS, Negrete GR, Konopelski JP. Asymmetric total synthesis of (+)-jasplakinolide. J Org Chem. 1991;56(17):5196–5202. doi: 10.1021/jo00017a037. [DOI] [Google Scholar]
  • 28.Inman W, Crews P. Novel marine sponge-derived amino acids. 8. Conformational analysis of jasplakinolide. J Am Chem Soc. 1989;111(8):2822–2829. doi: 10.1021/ja00190a013. [DOI] [Google Scholar]
  • 29.Kahn M, Nakanishi H, Su T, et al. Design and synthesis of nonpeptide mimetics of jaspamide. Int J Pept Protein Res. 1991;38(4):324–334. doi: 10.1111/j.1399-3011.1991.tb01511.x. [DOI] [PubMed] [Google Scholar]
  • 30.Ghosh AK, Moon DK. Enantioselective total synthesis of +-jasplakinolide. Org Lett. 2007;9(12):2425–2427. doi: 10.1021/ol070855h. [DOI] [PubMed] [Google Scholar]
  • 31.Scott VR, Boehme R, Matthews TR. New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species. Antimicrob Agents Chemother. 1988;32(8):1154–1157. doi: 10.1128/aac.32.8.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hable WE, Miller NR, Kropf DL. Polarity establishment requires dynamic actin in fucoid zygotes. Protoplasma. 2003;221(3–4):193–204. doi: 10.1007/s00709-002-0081-0. [DOI] [PubMed] [Google Scholar]
  • 33.Ou GS, Chen ZL, Yuan M. Jasplakinolide reversibly disrupts actin filaments in suspension-cultured tobacco BY-2 cells. Protoplasma. 2002;219(3–4):168–175. doi: 10.1007/s007090200018. [DOI] [PubMed] [Google Scholar]
  • 34.Cárdenas L, Lovy-Wheeler A, Wilsen KL, et al. Actin polymerization promotes the reversal of streaming in the apex of pollen tubes. Cell Motil Cytoskeleton. 2005;61(2):112–127. doi: 10.1002/cm.20068. [DOI] [PubMed] [Google Scholar]
  • 35.Thomas SG, Huang S, Li S, et al. Actin depolymerization is sufficient to induce programmed cell death in self-incompatible pollen. J Cell Biol. 2006;174(2):221–229. doi: 10.1083/jcb.200604011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Senderowicz AM, Kaur G, Sainz E, et al. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J Natl Cancer Inst. 1995;87(1):46–51. doi: 10.1093/jnci/87.1.46. [DOI] [PubMed] [Google Scholar]
  • 37.da Costa SR, Yarber FA, Zhang L, et al. Microtubules facilitate the stimulated secretion of beta-hexosaminidase in lacrimal acinar cells. J Cell Sci. 1998;111(Pt 9):1267–1276. doi: 10.1242/jcs.111.9.1267. [DOI] [PubMed] [Google Scholar]
  • 38.Holzinger A, Lütz-Meindl U. Chondramides, novel cyclodepsipeptides from myxobacteria, influence cell development and induce actin filament polymerization in the green alga Micrasterias. Cell Motil Cytoskeleton. 2001;48(2):87–95. doi: 10.1002/1097-0169(200102)48:2<87::AID-CM1000>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  • 39.Jansen R, Kunze B, Reichenbach H, et al. Chondramides A-D, new cytostatic and antifungal cyclodepsipeptides from Chondromyces crocatus (myxobacteria): Isolation and structure elucidation. Liebigs Ann. 1996:285–290. [Google Scholar]
  • 40.Ma CI, Diraviyam K, Maier ME, et al. Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii. Journal of natural products. 2013;76(9):1565–1572. doi: 10.1021/np400196w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Foerster F, Braig S, Moser C, et al. Targeting the actin cytoskeleton: selective antitumor action via trapping PKCε. Cell death & disease. 2014;5:e1398. doi: 10.1038/cddis.2014.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Menhofer MH, Kubisch R, Schreiner L, et al. The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility. PloS one. 2014;9(11):e112542. doi: 10.1371/journal.pone.0112542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Hussey PJ, Ketelaar T, Deeks MJ. Control of the actin cytoskeleton in plant cell growth. Annual review of plant biology. 2006;57:109–125. doi: 10.1146/annurev.arplant.57.032905.105206. [DOI] [PubMed] [Google Scholar]
  • 44.Url T, Höftberger M, Meindl U. Cytochalasin B influences dictyosomal vesicle production and mophogenesis in the desmid Euastrum. Journal of Phycology. 1993;29(5):667–674. doi: 10.1111/j.0022-3646.1993.00667.x. [DOI] [Google Scholar]
  • 45.Höftberger M, Lütz-Meindl U. Septum formation in the desmid Xanthidium (Chlorophyta): Effects of cytochalasin D and latruculin B suggest the involvement of actin microfilaments. J Phycol. 1999;35(4):768–777. doi: 10.1046/j.1529-8817.1999.3540768.x. [DOI] [Google Scholar]
  • 46.Foissner I, Wasteneys GO. Wide-ranging effects of eight cytochalasins and latrunculin A and B on intracellular motility and actin filament reorganization in characean internodal cells. Plant & cell physiology. 2007;48(4):585–597. doi: 10.1093/pcp/pcm030. [DOI] [PubMed] [Google Scholar]
  • 47.Gibbon BC, Kovar DR, Staiger CJ. Latrunculin B has different effects on pollen germination and tube growth. Plant Cell. 1999;11(12):2349–2363. doi: 10.1105/tpc.11.12.2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Scherlach K, Boettger D, Remme N, et al. The chemistry and biology of cytochalasans. Natural product reports. 2010;27(6):869–886. doi: 10.1039/b903913a. [DOI] [PubMed] [Google Scholar]
  • 49.Bonder EM. Cytochalasin B slows but does not prevent monomer addition at the barbed end of the actin filament. The Journal of Cell Biology. 1986;102(1):282–288. doi: 10.1083/jcb.102.1.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Aldridge DC, Armstrong JJ, Speake RN, et al. The cytochalasins, a new class of biologically active mould metabolites. Chem Commun (London) 1967;26(1) doi: 10.1039/c19670000026. [DOI] [Google Scholar]
  • 51.Rothweiler W, Tamm C. Isolation and structure of Phomin. Experientia. 1966;22(11):750–752. doi: 10.1007/BF01901360. [DOI] [Google Scholar]
  • 52.Coué M, Brenner SL, Spector I, et al. Inhibition of actin polymerization by latrunculin A. FEBS Letters. 1987;213(2):316–318. doi: 10.1016/0014-5793(87)81513-2. [DOI] [PubMed] [Google Scholar]
  • 53.Spector I, Shochet N, Kashman Y, et al. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science. 1983;219(4584):493–495. doi: 10.1126/science.6681676. [DOI] [PubMed] [Google Scholar]
  • 54.Baluska F, Jasik J, Edelmann HG, et al. Latrunculin B-induced plant dwarfism: Plant cell elongation is F-actin-dependent. Developmental Biology. 2001;231(1):113–124. doi: 10.1006/dbio.2000.0115. [DOI] [PubMed] [Google Scholar]
  • 55.Holzinger A, Wasteneys GO, Lütz C. Investigating cytoskeletal function in chloroplast protrusion formation in the arctic-alpine plant Oxyria digyna. Plant Biol (Stuttg) 2007;9(3):400–410. doi: 10.1055/s-2006-924727. [DOI] [PubMed] [Google Scholar]
  • 56.Carmely S, Kashman Y. Structure of swinholide-a, a new macrolide from the marine sponge Theonella swinhoei. Tetrahedron Letters. 1985;26(4):511–514. doi: 10.1016/S0040-4039(00)61925-1. [DOI] [Google Scholar]
  • 57.Bubb MR, Spector I, Bershadsky AD, et al. Swinholide A Is a Microfilament Disrupting Marine Toxin That Stabilizes Actin Dimers and Severs Actin Filaments. Journal of Biological Chemistry. 1995;270(8):3463–3466. doi: 10.1074/jbc.270.8.3463. [DOI] [PubMed] [Google Scholar]
  • 58.Klenchin VA, King R, Tanaka J, et al. Structural basis of swinholide A binding to actin. Chemistry & Biology. 2005;12(3):287–291. doi: 10.1016/j.chembiol.2005.02.011. [DOI] [PubMed] [Google Scholar]
  • 59.Posey SC, Bierer BE. Actin stabilization by jasplakinolide enhances apoptosis induced by cytokine deprivation. J Biol Chem. 1999;274(7):4259–4265. doi: 10.1074/jbc.274.7.4259. [DOI] [PubMed] [Google Scholar]
  • 60.Braet F, Spector I, Zanger R de, et al. A novel structure involved in the formation of liver endothelial cell fenestrae revealed by using the actin inhibitor misakinolide. Proc Natl Acad Sci U S A. 1998;95(23):13635–13640. doi: 10.1073/pnas.95.23.13635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Shurety W, Stewart NL, Stow JL. Fluid-phase markers in the basolateral endocytic pathway accumulate in response to the actin assembly-promoting drug Jasplakinolide. Mol Biol Cell. 1998;9(4):957–975. doi: 10.1091/mbc.9.4.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Shaw MK, Tilney LG. Induction of an acrosomal process in Toxoplasma gondii: visualization of actin filaments in a protozoan parasite. Proc Natl Acad Sci U S A. 1999;96(16):9095–9099. doi: 10.1073/pnas.96.16.9095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Sheahan MB, Staiger CJ, Rose RJ, et al. A green fluorescent protein fusion to actin-binding domain 2 of Arabidopsis fimbrin highlights new features of a dynamic actin cytoskeleton in live plant cells. Plant Physiol. 2004;136(4):3968–3978. doi: 10.1104/pp.104.049411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Voigt B, Timmers Antonius CJ, Samaj J, et al. GFP-FABD2 fusion construct allows in vivo visualization of the dynamic actin cytoskeleton in all cells of Arabidopsis seedlings. Eur J Cell Biol. 2005;84(6):595–608. doi: 10.1016/j.ejcb.2004.11.011. [DOI] [PubMed] [Google Scholar]
  • 65.Meindl U. Effects of temperature on cytomomorphogenesis and ultrastructure of Micrasterias denticulata Bréb. Protoplasma. 1990;157:3–18. [Google Scholar]
  • 66.Meindl U, Lancelle S, Hepler PK. Vesicle production and fusion during lobe formation in Micrasterias visualized by high-pressure freeze fixation. Protoplasma. 1992;170(3–4):104–114. doi: 10.1007/BF01378786. [DOI] [Google Scholar]
  • 67.Holzinger A, de Ruijter N, Emons AM, et al. Spectrin-like proteins in green algae (Desmidiaceae) Cell Biol Int. 1999;23(5):335–344. doi: 10.1006/cbir.1999.0365. [DOI] [PubMed] [Google Scholar]
  • 68.Baluska F, Parker JS, Barlow PW. Specific patterns of cortical and endoplasmic microtubules associated with cell growth and tissue differentiation in roots of maize (Zea mays L.) Journal of Cell Science. 1992;103(1):191–200. [Google Scholar]
  • 69.Chichili GR, Rodgers W. Clustering of membrane raft proteins by the actin cytoskeleton. J Biol Chem. 2007;282(50):36682–36691. doi: 10.1074/jbc.M702959200. [DOI] [PubMed] [Google Scholar]
  • 70.de Marino S, Festa C, D'Auria MV, et al. Swinholide J, a potent cytotoxin from the marine sponge Theonella swinhoei. Marine drugs. 2011;9(6):1133–1141. doi: 10.3390/md9061133. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES